Pulses: Optimizing Pulse Consumption for Cardiometabolic Health
University of Arizona · with United States Department of Agriculture (USDA) · NCT06861153
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 180
- US sites recruiting
- 1
- Study start
- July 1, 2025
- Record last updated
- August 19, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This randomized clinical trial aims to evaluate the effects of consuming two different doses of pulses (1.5 cups/week or 3 cups/week) in individuals with baseline intake below 1.5 cups/week, compared to a control group receiving standard nutrition education based on the United States Department of Agriculture's (USDA) My Plate guidelines.
The main question the Pulses study aims to answer is:
- What is the effect of increasing pulse consumption (in a dose-response manner) on specific cardiometabolic risk factors, including LDL-C, CRP, HBA1C, and blood pressure compared to standard nutrition education?
For secondary outcomes, this study aims to answer the following:
- Does increased pulse consumption improve the following: overall serum lipid profile (Total cholesterol (TC), HDL-C, Triglycerides (TG), diet quality (measured by the Healthy Eating Index), and participants self-reported satisfaction with life (SWLS) and Satisfaction with Food-related Life (SWFoL).
All participants will attend biweekly classes and food demonstrations. The pulses groups will learn to prepare various pulse-based recipes, while the control group will receive guidance on preparing healthy meals following the USDA MyPlate recommendations.
Being studied: Pulses 1.5 cups Group; Pulses 3 cups Group; My Plate Group (Control)
Conditions: Cardiovascular (CV) Risk; Healthy Eating Index; HbA1c; Lipid Profile; CRP
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- ≥ 18 years old (with no upper age limit)
- Currently consuming less than 1.5 cup-equivalents of pulses per week
- Willing and able to participate in a 12-week dietary intervention focused on increased pulse consumption
- Able to communicate in English and provide written informed consent
- Assessed as suitable to participate in a nutrition intervention by the study dietitian or primary healthcare provider
Exclusion Criteria
- Individuals already consuming >150 minutes/week of pulse-based dietary programming or otherwise regularly meeting high pulse intake benchmarks at baseline
- Patients with food allergies or intolerances that preclude the consumption of pulses
- Individuals who have not received clearance from their healthcare provider to make significant dietary modifications
- Participants anticipating major changes in dietary habits due to elective surgery, planned relocation, or other lifestyle alterations during the study period (12 weeks)
Recruiting US locations
University of Arizona
Tucson, AZ 85721
Site contact: Ken Wilund, PhD · 217-419-4087 · kwilund@arizona.edu
Study contacts (from the official record)
- Kenneth Wilud, PhD · 520-626-3718 · kwilund@arizona.edu
- Milad Hasankhani · 5208525064 · miladh@arizona.edu
Similar studies in Arizona
All nutrition & metabolism studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Chandler, AZ + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Chandler, AZ + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Chandler, AZ + 112 other US sites
- Eligibility basics
- Ages 18–75